Sponsored by

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 876 to 900 of about 5865

Previous 25

Website Changes

05/15/2020

Musella Foundation Webinar Series: A Promising New Radiotherapy for Recurrent Glioblastoma

05/13/2020

China NMPA Approves Optune® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma

05/13/2020

Plus Therapeutics Announces Patient-Focused Presentation Supporting Brain Tumor Awareness Month

05/09/2020

Brain Tumor Awareness MonthWebinar Series - Advances in neuro-imaging

05/05/2020

Improved Survival for GBM Patients Treated with DC Vaccine and Adjuvant TLR-3 Agonist in Phase II Clinical Trial

05/05/2020

Diverse Biotech announces orphan-drug designation for treatment of newly diagnosed glioblastoma

05/03/2020

Brain Tumor Awareness Month Seminar Series continues tonight at 7pm eastern time

04/30/2020

Having sold its corporate self, Tocagen auctions off scientific platform to San Diego biotech

04/30/2020

Pharmacokinetics, Safety and Tolerability of Olaparib and Temozolomide for Recurrent Glioblastoma: Results of the Phase I OPARATIC Trial

04/30/2020

UNIQUE GREETING CARDS TAKE ON NEW MEANING IN THE ERA OF COVID-19

04/29/2020

Musella Foundation Webinar Series: This Sunday

04/27/2020

CT103 - Final results for OptimalTTF-1: Optimizing Tumor Treating Fields with targeted skull remodeling surgery for first recurrence glioblastoma: Phase 1 trial

04/27/2020

EF-19 - A post-approval registry study of TTFields for the treatment of recurrent glioblastoma (GBM)

04/27/2020

CBD Shows Promise For Fighting Aggressive Brain Cancer

04/25/2020

A Phase II Randomized, Multicenter, Open-Label Trial of Continuing Adjuvant Temozolomide Beyond Six Cycles in Patients With Glioblastoma (GEINO 14-01)

04/24/2020

Immunotherapies combine for triple threat against deadly brain cancer

04/23/2020

Reinforcement Learning for Optimal Scheduling of Glioblastoma Treatment With Temozolomide

04/23/2020

Surveys! We need your participation!

04/18/2020

NW Bio To Discuss Projected Schedule For Data Lock, Unblinding and Top Line Data From Its Phase 3 Clinical Trial At Annual Shareholder Meeting

04/17/2020

Lessons Learned in Using Laser Interstitial Thermal Therapy (LITT) for Treatment of Brain Tumors: A Case Series of 238 Patients From A Single Institution

04/10/2020

Musella Foundation Webinar Series: This Sunday 4/12/2020

04/10/2020

Prophylactic Anticonvulsant Therapy in High-Grade Glioma: A Systematic Review and Meta-Analysis of Longitudinal Studies

04/08/2020

Study Shows Possible Alternative Treatment for High-Grade Glioma Tumors in Infants

04/06/2020

Stereotactic Radiotherapy in Recurrent Glioblastoma: A Valid Salvage Treatment Option.

04/05/2020

Brain Tumor Patients and the COVID-19 Crisis! Live Webinar tonight (4/5/2020) 7pm Eastern Time

Our privacy / cookie policy has changed.
Click HERE to read it!